Cyanidin-3-O-Glucoside Improves Colonic Motility During Severe Acute Pancreatitis by Inhibiting the H₂S-Regulated AMPK/mTOR Pathway

References

• BollenTL. Acute pancreatitis: international classification and nomenclature. Clin Radiol. 2016;71(2):121–133. doi:10.1016/j.crad.2015.09.01326602933
   PubMed Web of Science ®Google Scholar
• LeppaniemiA, TolonenM, TarasconiA, et al. 2019 WSES guidelines for the management of severe acute pancreatitis. World J Emerg Surg. 2019;14:27.31210778
   PubMed Web of Science ®Google Scholar
• PortelliM, JonesCD. Severe acute pancreatitis: pathogenesis, diagnosis and surgical management. Hepatobiliary Pancreat Dis Int. 2017;16(2):155–159. doi:10.1016/S1499-3872(16)60163-728381378
   PubMed Web of Science ®Google Scholar
• HuangL, JiangY, SunZ, GaoZ, WangJ, ZhangD. Autophagy strengthens intestinal mucosal barrier by attenuating oxidative stress in severe acute pancreatitis. Digest Dis Sci. 2018;63(4):910–919. doi:10.1007/s10620-018-4962-229427225
   PubMed Web of Science ®Google Scholar
• WenW, ZhengH, JiangY, et al. Effect of intestinal epithelial autophagy on bacterial translocation in severe acute pancreatitis. Clin Res Hepatol Gas. 2017;41(6):703–710. doi:10.1016/j.clinre.2017.03.007
   PubMed Web of Science ®Google Scholar
• PiaoX, LiuB, GuoL, MengF, GaoL. Picroside II shows protective functions for severe acute pancreatitis in rats by preventing NF-kappaB-dependent autophagy. Oxid Med Cell Longev. 2017;7085709(10):21.
   Google Scholar
• XiongJ, WangK, YuanC, et al. Luteolin protects mice from severe acute pancreatitis by exerting HO-1-mediated anti-inflammatory and antioxidant effects. Int J Mol Med. 2017;39(1):113–125. doi:10.3892/ijmm.2016.280927878246
   PubMed Web of Science ®Google Scholar
• LiuMW, WeiR, SuMX, LiH, FangTW, ZhangW. Effects of panax notoginseng saponins on severe acute pancreatitis through the regulation of mTOR/Akt and caspase-3 signaling pathway by upregulating miR-181b expression in rats. BMC Complement Altern Med. 2018;18(1):018–2118. doi:10.1186/s12906-018-2118-8
   PubMed Web of Science ®Google Scholar
• MaZ, SongG, LiuD, et al. N-acetylcysteine enhances the therapeutic efficacy of bone marrow-derived mesenchymal stem cell transplantation in rats with severe acute pancreatitis. Pancreatology. 2019;19(2):258–265. doi:10.1016/j.pan.2019.01.00430660392
   PubMed Web of Science ®Google Scholar
• XiaoQ, YingJ, XiangL, ZhangC. The biologic effect of hydrogen sulfide and its function in various diseases. Medicine. 2018;97(44):0000000000013065. doi:10.1097/MD.0000000000013065
   Web of Science ®Google Scholar
• WuDD, WangDY, LiHM, GuoJC, DuanSF, JiXY. Hydrogen sulfide as a novel regulatory factor in liver health and disease. Oxid Med Cell Longev. 2019;20(3831713).
   Google Scholar
• WenYD, WangH, ZhuYZ. The drug developments of hydrogen sulfide on cardiovascular disease. Oxid Med Cell Longev. 2018;2018:4010395. doi:10.1155/2018/401039530151069
   PubMed Web of Science ®Google Scholar
• DombkowskiRA, NaylorMG, ShoemakerE, et al. Hydrogen sulfide (H2S) and hypoxia inhibit salmonid gastrointestinal motility: evidence for H2S as an oxygen sensor. J Exp Biol. 2011;214(23):4030–4040. doi:10.1242/jeb.06147322071195
   PubMed Web of Science ®Google Scholar
• FarrugiaG, SzurszewskiJH. Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract. Gastroenterology. 2014;147(2):303–313. doi:10.1053/j.gastro.2014.04.04124798417
   PubMed Web of Science ®Google Scholar
• WallaceJL, CaliendoG, SantagadaV, CirinoG, FiorucciS. Gastrointestinal safety and anti-inflammatory effects of a hydrogen sulfide-releasing diclofenac derivative in the rat. Gastroenterology. 2007;132(1):261–271. doi:10.1053/j.gastro.2006.11.04217241876
   PubMed Web of Science ®Google Scholar
• TamizhselviR, MoorePM. Hydrogen sulfide acts as a mediator of inflammation in acute pancreatitis: in vitro studies using isolated mouse pancreatic acinar cells. J Cell Mol Med. 2007;11(2):12. doi:10.1111/j.1582-4934.2007.00024.x
   Web of Science ®Google Scholar
• VomeroND, ColpoE. Nutritional care in peptic ulcer. Arq Bras Cir Dig. 2014;27(4):298–302. doi:10.1590/S0102-6720201400040001725626944
   PubMedGoogle Scholar
• Sandoval-RamirezBA, CatalanU, Fernandez-CastillejoS, RubioL, MaciaA, SolaR. Anthocyanin tissue bioavailability in animals: possible implications for human health. A systematic review. J Agr Food Chem. 2018;66(44):11531–11543. doi:10.1021/acs.jafc.8b0401430345762
   PubMed Web of Science ®Google Scholar
• Ming-MingM, YanL, Xiang-YongL, et al. Cyanidin-3-O-glucoside ameliorates lipopolysaccharide-induced injury both in vivo and in vitro suppression of NF-κB and MAPK pathways. Inflammation. 2015;38(4):1669–1682. doi:10.1007/s10753-015-0144-y25752620
   PubMed Web of Science ®Google Scholar
• Jung-MinK, Kyung-MiK, En-HeeP, et al. Anthocyanins from black soybean inhibit Helicobacter pylori-induced inflammation in human gastric epithelial AGS cells. Microbiol Immunol. 2013;57(5):366–373. doi:10.1111/1348-0421.1204923668609
   PubMed Web of Science ®Google Scholar
• KaltW, CassidyA, HowardLR, et al. Recent research on the health benefits of blueberries and their anthocyanins. Adv Nutr. 2019;22(5536953).
   Google Scholar
• AntonioS, SirajudheenA, RaffaellaC, et al. Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway. Mol Nutr Food Res. 2013;57(11):1979–1987. doi:10.1002/mnfr.20130010223901008
   PubMed Web of Science ®Google Scholar
• WangQ, XiaM, LiuC, et al. Cyanidin-3-O-beta-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor alpha activation in THP-1 macrophages. Life Sci. 2008;83(5):176–184. doi:10.1016/j.lfs.2008.05.01718619979
   PubMed Web of Science ®Google Scholar
• SpecialeA, CanaliR, ChirafisiJ, SaijaA, VirgiliF, CiminoF. Cyanidin-3-O-glucoside protection against TNF-alpha-induced endothelial dysfunction: involvement of nuclear factor-kappaB signaling. J Agr Food Chem. 2010;58(22):12048–12054. doi:10.1021/jf102951520958056
   PubMed Web of Science ®Google Scholar
• WangH, ZhongP, SunL. Exogenous hydrogen sulfide mitigates NLRP3 inflammasome-mediated inflammation through promoting autophagy via the AMPK-mTOR pathway. Biol Open. 2019;8(7):bio043653. doi:10.1242/bio.04365331315822
   PubMed Web of Science ®Google Scholar
• MurakamiT, KamadaK, MizushimaK, et al. Changes in intestinal motility and gut microbiota composition in a rat stress model. Digestion. 2017;95(1):55–60. doi:10.1159/00045236428052282
   PubMed Web of Science ®Google Scholar
• KangK, ZhaoM, JiangH, TanG, PanS, SunX. Role of hydrogen sulfide in hepatic ischemia-reperfusion-induced injury in rats. Liver Transpl. 2009;15(10):1306–1314. doi:10.1002/lt.2181019790158
   PubMed Web of Science ®Google Scholar
• TangG, WuL, LiangW, WangR. Direct stimulation of K ATP channels by exogenous and endogenous hydrogen sulfide in vascular smooth muscle cells. Mol Pharmacol. 2005;68(6):1757–1764. doi:10.1124/mol.105.01746716150926
   PubMed Web of Science ®Google Scholar
• RosadoJO, SalvadorM, BonattoD. Importance of the trans-sulfuration pathway in cancer prevention and promotion. Mol Cell Biochem. 2007;301(1–2):1–12. doi:10.1007/s11010-006-9389-y17180248
   PubMed Web of Science ®Google Scholar
• TessariP, CecchetD, VettoreM, CoracinaA, PuricelliL, KiwanukaE. Decreased homocysteine trans-sulfuration in hypertension with hyperhomocysteinemia: relationship with insulin resistance. J Clin Endocrinol Metab. 2018;103(1):56–63. doi:10.1210/jc.2017-0107629029082
   PubMed Web of Science ®Google Scholar
• TamizhselviR, KohYH, SunJ, ZhangH, BhatiaM. Hydrogen sulfide induces ICAM-1 expression and neutrophil adhesion to caerulein-treated pancreatic acinar cells through NF-kappaB and Src-family kinases pathway. Exp Cell Res. 2010;316(9):1625–1636. doi:10.1016/j.yexcr.2010.02.04420211170
   PubMed Web of Science ®Google Scholar
• HegdeA, BhatiaM. Hydrogen sulfide in inflammation: friend or foe? Inflamm Allergy Drug Targets. 2011;10(2):118–122. doi:10.2174/18715281179477626821275899
   PubMedGoogle Scholar
• WhitemanM, WinyardPG. Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol. 2011;4(1):13–32. doi:10.1586/ecp.10.13422115346
   PubMedGoogle Scholar